Georgia Medicare hepatitis B screening costs you nothing if you are pregnant or at high risk and a primary care clinician orders it at an office visit. Medicare Part B covers the hepatitis B (HBV) three-test panel at $0 when your provider accepts assignment. The hepatitis B vaccine is also $0 under Part B on any of three conditions: no complete vaccine series, unknown vaccination history, or medium-to-high risk such as diabetes. This guide explains who qualifies, what the tests and vaccine cost, and where to get care in Georgia.

Hepatitis B matters especially in Georgia. Chronic HBV infection is far more common in the Asian American and African immigrant communities concentrated in metro Atlanta, where many people acquired the virus at birth and have carried it silently for decades. Screening finds those infections so they can be treated, and vaccination prevents new ones. The catch that trips up many beneficiaries: the screening blood test and the vaccine follow two different Medicare coverage rules, and neither is automatically free for everyone. This guide walks through both.

Georgia Medicare Hepatitis B Screening: What Part B Covers

Medicare Part B covers hepatitis B screening at $0 to the beneficiary, with no deductible and no coinsurance when the provider accepts assignment, for people who are pregnant or at high risk for HBV infection. The coverage flows from the additional-preventive-services authority in Social Security Act Section 1861(ddd), and federal regulation lets Medicare add a screening benefit that way only where the United States Preventive Services Task Force (USPSTF) has recommended it with an A or B grade. CMS put the hepatitis B screening benefit in place through Change Request 9859, effective for services on or after September 28, 2016, and it sets two requirements: a provider has to order the screening, and you have to meet one of the two qualifying conditions, high risk for HBV infection or pregnancy.

Who orders it, and where, decides whether Medicare pays. CMS covers the screening when your primary care physician or practitioner orders it in a primary care setting and an eligible Medicare provider performs it in that setting too. Emergency departments, inpatient hospital stays, skilled nursing facilities, inpatient rehabilitation facilities, ambulatory surgical centers, limited-focus clinics and hospice don't count as primary care settings, and a claim without the right place-of-service code is denied. The ordering clinician also has to come from a specialty CMS lists, which includes general and family practice, internal medicine, obstetrics/gynecology, geriatric medicine, nurse practitioners, certified nurse midwives, clinical nurse specialists and physician assistants. So the practical move is to have your primary care doctor, nurse practitioner or geriatrician order it at an office visit, not tack it onto a hospital stay, a nursing-home stay or hospice care.

Hepatitis B screening sits inside Medicare's broader set of preventive and screening services, most of which Part B covers at $0 as long as the provider accepts assignment, each with its own eligibility conditions and frequency limits. Because the risk categories are broad and many people never knew they were exposed, clinicians often screen widely. A beneficiary who does not fall into a covered category can still be tested, but the $0 preventive benefit may not apply, so ask the provider what Medicare will actually pay before the test.

Who Qualifies for Georgia Medicare Hepatitis B Screening

Two groups get hepatitis B screening at no cost: beneficiaries who are pregnant, and beneficiaries at high risk for HBV infection. Either way, a provider has to order it, and high risk isn't something you declare yourself: your primary care provider identifies it from your history, typically at an annual wellness visit. CMS defines high risk as:,

  • People born in countries or regions where hepatitis B prevalence is 2 percent or higher.
  • U.S.-born people not vaccinated as infants whose parents were born in regions where prevalence is 8 percent or higher.
  • People with HIV infection.
  • Men who have sex with men.
  • People who inject drugs.
  • Household contacts or sexual partners of people with hepatitis B infection.

That first category is the one that matters most in Georgia. Hepatitis B is common across much of East Asia, Southeast Asia, the Pacific Islands, and sub-Saharan Africa, so for many beneficiaries born there, country of birth alone is what puts them in the covered group.

The USPSTF's broader at-risk list, which many clinicians work from, also takes in people with multiple sexual partners or a history of a sexually transmitted infection, healthcare and public-safety workers with blood or body-fluid exposure, and people on long-term hemodialysis. Those groups sit outside the categories CMS's guidance names, so ask the provider how the test will be billed before assuming it comes at no cost.

Repeat screening is narrower than the first test. Medicare covers a yearly rescreen only for people at continued high risk in three of those categories (men who have sex with men, people who inject drugs, and household contacts or sexual partners of someone with hepatitis B), and only if they haven't received the hepatitis B vaccine. A beneficiary who qualified through country of birth, a parent's country of birth, or HIV isn't named in the yearly-repeat rule, so ask the provider what Medicare will pay before booking a second screening. For those groups, getting vaccinated ends coverage of the yearly repeat, a fair trade for the protection the shot gives.

Pregnancy runs on its own, more generous schedule. Medicare covers a screening at the first prenatal visit of each pregnancy, even after earlier vaccination or a past negative surface-antigen test, and rescreening at delivery for anyone with new or continuing risk factors.,

The HCPCS G0499 Three-Test Panel

Medicare bills hepatitis B screening for a non-pregnant beneficiary at high risk under HCPCS code G0499; screening during pregnancy is billed under CPT codes 86704, 86706, 87340 and 87341 instead. The G0499 screening runs as a three-test panel:

  • HBsAg (hepatitis B surface antigen): a positive result signals current infection.
  • Anti-HBs (antibody to surface antigen): a positive result signals immunity, from either vaccination or a resolved past infection.
  • Anti-HBc (antibody to core antigen): a positive result signals past or present infection; it does not come from the vaccine.

Read together, the three tests separate the main possibilities:

  • Susceptible (never infected, never vaccinated): all three negative. A candidate for vaccination.
  • Vaccine-induced immunity: HBsAg negative, anti-HBs positive, anti-HBc negative.
  • Past resolved infection with immunity: HBsAg negative, anti-HBs positive, anti-HBc positive.
  • Chronic infection: HBsAg positive (persisting longer than six months), anti-HBc positive. This result needs linkage to hepatology care.
  • Isolated anti-HBc: only anti-HBc positive. An ambiguous pattern that may need follow-up testing, including an HBV DNA test.

When screening finds chronic infection, follow-up tests (HBV DNA viral load, liver enzymes, a fibrosis assessment such as FibroScan, and hepatocellular carcinoma surveillance imaging) guide treatment. Those diagnostic tests are covered under standard Part B cost-sharing, not the no-cost screening waiver.

What Hepatitis B Screening and Vaccination Cost

Screening: $0. Hepatitis B screening costs the beneficiary nothing when a primary care clinician orders it for a pregnant or high-risk beneficiary in a primary care setting and the provider accepts assignment. The Part B deductible and coinsurance are waived. What you owe can still depend on other insurance, what the doctor charges, the type of facility and where the service is done, and a yearly repeat is covered only for the continued-risk groups above.,

Vaccine: $0 on any one of three conditions. Medicare Part B covers the hepatitis B vaccine and its administration at $0 if you meet at least one of three conditions: you never got a complete hepatitis B series, you do not know your vaccination history, or you have a health condition or situation that puts you at medium or high risk (diabetes, end-stage renal disease, or living with someone who has hepatitis B). Medium or high risk is one route in, not a requirement. In practice, the person who meets none of the three is someone who knows they finished a series and isn't at medium or high risk, and Part B's $0 vaccine benefit doesn't extend to them.

The Inflation Reduction Act made all Advisory Committee on Immunization Practices (ACIP)-recommended vaccines under Part D free (no deductible, no copay) as of January 1, 2023, which is why the shingles, RSV, and Tdap vaccines now cost nothing. But the hepatitis B vaccine is a Part B vaccine, not a Part D one, so it keeps the Part B three-condition rule rather than being free for everyone.

Antiviral treatment: through Part D. If screening finds chronic hepatitis B that needs treatment, the antiviral drugs (tenofovir alafenamide, tenofovir disoproxil fumarate, or entecavir) are covered under Medicare Part D, usually with prior authorization. Because treatment is long-term, the Inflation Reduction Act's Part D out-of-pocket cap matters: annual out-of-pocket spending on covered drugs is capped at $2,000 in 2025 and $2,100 in 2026, after which you pay $0 for the rest of the year.

Downstream care: Confirmatory testing, hepatology visits, and cancer-surveillance imaging carry standard Part B cost-sharing. A Medigap policy, or Medicaid for a dually eligible beneficiary, can reduce or eliminate those amounts.

The Hepatitis B Vaccine Under Medicare Part B

The hepatitis B vaccine is one of the preventive vaccines Part B covers by statute. It's $0 for a beneficiary who meets any one of Medicare's three conditions and whose provider accepts assignment; Part B's vaccine benefit doesn't cover someone who meets none of them.

For a susceptible beneficiary who qualifies, the vaccine is given as a series: a three-dose schedule (Engerix-B, Recombivax HB, or PreHevbrio) or a two-dose schedule (Heplisav-B). Post-vaccination antibody testing is not routine for healthy adults, though it is sometimes done for people with high exposure risk. Beneficiaries who think they were vaccinated years ago but lack records can have an anti-HBs test to check whether they are still immune.

Hepatitis B in Georgia's Communities

Hepatitis B is unevenly distributed. In the United States it is uncommon in the general population but substantially more common in people born in East Asia, Southeast Asia, the Pacific Islands, and sub-Saharan Africa, where most infections are passed from mother to child at birth. Asian Americans and African immigrants together account for a large share of chronic hepatitis B in the country, and many of those infections have been silent for decades. Left untreated, chronic hepatitis B is a leading cause of cirrhosis and liver cancer, which is exactly why finding it early changes outcomes.

Georgia carries meaningful concentrations of higher-risk populations:

  • Metro Atlanta has the Southeast's largest Asian American population, with substantial Korean, Vietnamese, Chinese, Indian, and Filipino communities, notably along the Buford Highway corridor in DeKalb and Gwinnett counties.
  • African immigrant communities from Ethiopia, Nigeria, Somalia, Sudan, and the Democratic Republic of Congo are substantial across metro Atlanta.
  • Refugees from high-prevalence countries have been resettled in Georgia, particularly around Clarkston in DeKalb County.

For beneficiaries from these communities, country of birth alone is a covered screening risk factor, so screening is both covered and high-value. Family-based screening matters too: when screening finds chronic hepatitis B in one person, household members and sexual partners should be screened and, if susceptible, vaccinated.

Getting Care in Georgia

Covered hepatitis B screening has to be ordered in a primary care setting, so start with your primary care practice or a community health center; the vaccine is available at any Medicare-enrolled provider, including pharmacies and community health centers. For chronic hepatitis B that needs specialty management, major Georgia hepatology programs at Emory, Wellstar, Piedmont, Northside, and Augusta University provide antiviral treatment, liver-cancer surveillance, and transplant evaluation. Federally Qualified Health Centers across Georgia offer screening and integrated care for immigrant and medically underserved communities, often with multilingual staff.

Community health organizations, including the Center for Pan Asian Community Services (CPACS) and refugee-focused agencies in the Clarkston area, support culturally and linguistically appropriate hepatitis B education and screening. Beneficiaries with HIV and hepatitis B coinfection can coordinate care through Ryan White HIV/AIDS Program-funded clinics in metro Atlanta.

Worked Examples

These scenarios are illustrative composites, not real individuals, and are meant to show how the coverage rules play out.

A Vietnamese American man whose screening finds chronic hepatitis B

A 68-year-old man in Fulton County, on Original Medicare, immigrated from Vietnam decades ago and has never been screened. His primary care provider, recognizing country of birth as a covered risk factor, orders the G0499 panel at an office visit, at $0. The result (HBsAg positive, anti-HBc positive) shows chronic infection. He is referred to Emory Hepatology, started on a Part D antiviral with prior authorization, and set up for twice-yearly liver-cancer surveillance. His wife and adult children are screened; his susceptible daughter is offered vaccination. The screening cost him nothing; his Medigap plan and the Part D out-of-pocket cap hold down the downstream costs.

An Ethiopian immigrant with a resolved past infection

A 70-year-old woman in Clarkston, dually eligible for Medicare and Georgia Medicaid, was born in Ethiopia and has never been screened. Because country of birth is a covered risk factor, her nurse practitioner at the FQHC orders the G0499 panel at $0. The result (only anti-HBc positive) is ambiguous, so a follow-up HBV DNA test is done; it is negative, consistent with a past infection that resolved on its own. She needs no antiviral treatment. Her Medicaid coverage picks up the diagnostic HBV DNA test's Part B cost-sharing.

A beneficiary with diabetes who qualifies for the $0 vaccine

A 67-year-old woman in Cobb County has type 2 diabetes and is not immune to hepatitis B. Because diabetes puts her at medium-to-high risk, Medicare Part B covers her hepatitis B vaccine at $0 when her provider accepts assignment. She completes the two-dose Heplisav-B series. A neighbor the same age with no risk conditions asks about the vaccine and learns she qualifies anyway: she never completed a hepatitis B series, which is one of Medicare's three conditions on its own.

HIV and hepatitis B coinfection

A 72-year-old man in DeKalb County on Original Medicare has long-standing chronic hepatitis B and HIV, managed jointly by Emory hepatology and infectious disease. His antiretroviral regimen contains tenofovir, which suppresses both viruses at once, so his Part D coverage of HIV therapy also covers his hepatitis B antiviral needs. He gets twice-yearly liver-cancer surveillance and stays virally suppressed on both fronts.

Frequently Asked Questions

Who qualifies for $0 hepatitis B screening under Medicare?

Beneficiaries who are pregnant or at high risk for HBV infection get the screening at no cost when a primary care clinician orders it in a primary care setting, with the Part B deductible and coinsurance waived when the provider accepts assignment, under Social Security Act Section 1861(ddd). A yearly repeat is covered only for people at continued high risk in certain categories who haven't been vaccinated.,

What does the hepatitis B vaccine cost under Medicare?

Medicare Part B covers the hepatitis B vaccine at $0 if you meet any one of three conditions: you never got a complete series, you do not know your vaccination history, or you are at medium or high risk, when the provider accepts assignment. Part B's $0 vaccine benefit doesn't extend to someone who meets none of them.

Didn't the Inflation Reduction Act make all vaccines free?

The Inflation Reduction Act made ACIP-recommended vaccines under Part D free as of January 1, 2023, which is why shingles, RSV, and Tdap now cost nothing. The hepatitis B vaccine is a Part B vaccine, so it keeps the Part B three-condition rule rather than being free for everyone.

What is the HCPCS code for hepatitis B screening?

HCPCS G0499 is the code for screening a non-pregnant beneficiary at high risk; screening during pregnancy is billed under CPT codes 86704, 86706, 87340 and 87341 instead. G0499 is a single three-test panel covering HBsAg, anti-HBs, and anti-HBc.

What does the three-test panel tell my doctor?

HBsAg positive means current infection; anti-HBs positive means immunity (from vaccine or resolved infection); anti-HBc positive means past or present infection and never comes from the vaccine. The combination distinguishes susceptibility, immunity, resolved infection, and chronic infection.

Is chronic hepatitis B curable?

Current antivirals suppress the virus and sharply reduce liver damage but do not cure the infection, so treatment is usually long-term. A small number of people achieve a functional cure with sustained treatment.

Does Medicare Advantage cover hepatitis B screening and the vaccine?

Yes. Medicare Advantage plans must cover these benefits at least as well as Original Medicare, on the same cost-sharing terms. If a plan denies a covered service, you can appeal.

Where can I get help understanding my coverage?

Call Georgia SHIP (GeorgiaCares) at 1-866-552-4464, option 4, for free, unbiased Medicare counseling, or 1-800-MEDICARE for claim questions.,

Resources and Contacts

Palmetto GBA (Georgia Medicare Administrative Contractor) Adjudicates hepatitis B screening and vaccine claims in Georgia. 1-866-238-9650 palmettogba.com
Georgia Medicaid Member Services Georgia Medicaid benefit, ID card and provider questions for dually eligible beneficiaries. For eligibility questions, call the Gateway Customer Service Center at 1-877-423-4746. 1-866-211-0950https://www.medicaid.gov/about-us/where-can-people-get-help-medicaid-chip
American Liver Foundation Hepatitis B patient education and support. 1-800-465-4837
Hepatitis B Foundation Hepatitis B-specific patient education and advocacy. 215-489-4900
Georgia Department of Public Health Viral hepatitis surveillance and prevention programs. dph.georgia.gov
Eldercare Locator Connects you to your local Area Agency on Aging. 1-800-677-1116https://eldercare.acl.gov/home · Accessed Sep 2, 2026 eldercare.acl.gov

Learn More

Find personalized help understanding your Medicare hepatitis B screening and vaccination benefits at brevy.com.


The information on Brevy.com is for educational purposes only and is not a substitute for professional legal, financial, or medical advice. Rules vary by state and program and change frequently. Always verify with the relevant agency or a qualified professional. Brevy is not a law firm, financial advisor, or healthcare provider.

Still have questions?

Brevy answers from this guide and every other guide here, and can check what you qualify for.

BC

Brevy Care Team

Expert eldercare guidance from Brevy's team of healthcare professionals and researchers.